The increased insulin sensitivity in tumoral area could promote tumor growth in an independent Wnt signaling pathway (under dependent-insulin pathway), since SFRP2 is considered an adipokines that promotes insulin sensitivity and insulin resistance [34]. Here, SFRP2 is linked to neoplasm.